Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Add To Watchlist

Recent & Breaking News (NYSE:JNJ)

Decision Diagnostics' Board Votes to Uplist to OTC QX

Marketwired December 10, 2013

Australian DePuy ASR Lawsuit Being Prepped for Trial, as Proposed DePuy ASR Recall Settlement Moves Forward in U.S., Bernstein Liebhard LLP Reports

PR Newswire December 3, 2013

Johnson & Johnson to Participate in Credit Suisse 2013 Health Care Conference

PR Newswire November 5, 2013

Johnson & Johnson and its Subsidiaries, Janssen Pharmaceuticals, Inc. and Scios Inc., Conclude Previously Disclosed Settlement Agreements with U.S. Department of Justice and 45 States

PR Newswire November 4, 2013

OxySure Systems: Undervalued, High Growth Potential

Accesswire October 23, 2013

Five Star Equities Issues New Research Reports on AZN, DPZ, DXCM and JNJ

Accesswire October 23, 2013

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2013

PR Newswire October 17, 2013

Only One in Five People Consistently Recycles Packaging from Products Used in the Bathroom

PR Newswire October 17, 2013

Johnson & Johnson Reports 2013 Third-Quarter Results:

PR Newswire October 15, 2013

Former FDA Commissioner, Dr. Mark B. McClellan, to Join Johnson & Johnson Board of Directors

PR Newswire October 14, 2013

Three-Year Data Demonstrates Sustained Improvements in Health Related Quality of Life in Patients with Superficial Femoral Artery Disease Treated with the S.M.A.R.T.® Stent

Business Wire October 8, 2013

Pharma-Bio Industry to Invest $4.3 Billion in Capital/MRO Project Starts in Fourth-Quarter 2013, an Industrial Info News Alert

Marketwired October 7, 2013

Decision Diagnostics' Pharma Tech Division Schedules Shipments for Its Popular GenStrip Test Strip

Accesswire October 3, 2013

Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for Its Popular GenStrip Test Strip

Marketwired October 1, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on JNJ, MAKO, SYK and WMGI

Accesswire September 23, 2013

Johnson & Johnson to Host Conference Call on Third-Quarter Results

PR Newswire September 17, 2013

VisionCare Ophthalmic Technologies Secures Up To $15MM To Accelerate Growth Of Its Novel Treatment For Age-Related Macular Degeneration

PR Newswire September 17, 2013

Decision Diagnostics Corp. Announces Completion and Airing of Its New Genstrip Video Titled "A Patchwork of Life"

Marketwired September 10, 2013

Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference

PR Newswire September 4, 2013

Kessler Topaz Meltzer & Check, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Johnson & Johnson Common Stock -- JNJ

PR Newswire September 3, 2013